However, given the complexity of the pathogenesis and pathophysiology of PCOS, it is important to further investigate the molecular mechanisms underlying PCOS and to explore the mechanisms of action of CRY in order to propel this molecule in the treatment of PCOS. This evidence concerns the gene CRYL1 and polycystic ovary syndrome.